William Newell

Newell has over 10 years of senior management experience in the biotechnology industry. He joined Sutro Biopharma as CEO in January 2009.

Previously, he served as the President of Aerovance, Inc., a venture-backed company developing clinical assets for respiratory diseases.

Newell also was Chief Business Officer and Senior Vice President at publicly-traded QLT, Inc. and served in several senior management positions at public-traded Axys Pharmaceuticals, Inc, where he ultimately served as Senior Vice President, Corporate and Business Development prior to Celera Genomics’s acquisition of Axys.

For the 15 years prior to joining Axys, Mr. Newell practiced law at the law firm of Bingham McCutchen LLP.

William Newell is the Chief Executive Officer at Sutro Biopharma, based in United States, North America. With a background in Information Technology, William Newell has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.